Hepagene 雅创医药

Hepagene.com

雅创医药

ABOUT HEPAGENE

Non-alcoholic Steatohepatitis (NASH)

Chronic Hepatitis B Infection (HBV)

PIPELINE

Hepagene Therapeutics, Inc, Announces Dosing of First Healthy Subject in a Phase I Study of HPG1860 for NASH

About HPG1860

About NASH

About Hepagene Therapeutics, Inc

MANAGEMENT TEAM

ABOUT HEPAGENE
Hepagene Therapeutics, Inc. a clinical stage drug discovery and development company, devotes its efforttowards discovering, developing and delivering innovative medicines that help patients prevail over liverdiseases and other life-threatening diseases, especially non-alcoholic steatohepatitis (NASH),chronic Hepatitis B infection (HBV) and Hepatocellular Carcinoma (HCC).